Purpose. Analysis of the cataract surgery visual outcomes and advantages of intraocular lens Synthesis SIPY.Material and methods. We have operated 43 eyes with cataract (38 patients) using Synthesis SIPY lens. Non-corrected visual acuity was 0.13 ± 0.08, best corrected visual acuity (BCVA) was 0.36 ± 0.1.Results. Following 7 months, secondary cataract was not detected in any patient, what explain the actuality of square edge optical part on 360° of perimeter. The lens is inserted in cartridge in factory sterile conditions which exclude the contact between lens and environment, reduce the risk of incorrect inserting of the lens in cartridge following pinching by the cartridge flaps and, subsequently, the haptic tearing off. This complex “lens-cartridge” excludes the damage of haptics and optic parts, which can occur in using other IOLs during the removal of the lens from the vial and placing it in the groove of the cartridge. Position of cartridge in injector centralizes the cartridge tunnel for the Accuject Pro injector plunger, thereby reducing the risk of pinching the rubber tip of the IOL haptic plunger during implantation. The diameter of the cartridge tip allows the IOL to be implanted through a 1.6 mm tunnel. The uncorrected visual acuity after surgery was 0.6 ± 0.28. The best corrected visual acuity was 0.78 ± 0.24.Conclusions. The Synthesis SIPY lens has a number of advantages: factory installation of the lens into the cartridge and compatibility of the cartridge with the Accuject Pro injector prevent damage to the IOL; Implantation of the Synthesis SIPY lens is possible through the 1.6 mm corneal tunnel; high diopter ranges from -10.0D to + 40.0D allows for maximum visual results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.